Cargando…
Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status
Rapid tumour progression in neuroblastoma is associated with MYCN amplification, deletion of the short arm of chromosome 1 and gain of 17q. However, patients with advanced disease without MYCN amplification and/or 1p deletion have a very poor outcome too, which suggests other genetic defects may pre...
Autores principales: | Cunsolo, C Lo, Bicocchi, M P, Petti, A R, Tonini, G P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408785/ https://www.ncbi.nlm.nih.gov/pubmed/11044353 http://dx.doi.org/10.1054/bjoc.2000.1432 |
Ejemplares similares
-
Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes
por: Angelis, P M De, et al.
Publicado: (1999) -
An experimental loop design for the detection of constitutional chromosomal aberrations by array CGH
por: Allemeersch, Joke, et al.
Publicado: (2009) -
Chromosome instability in neuroblastoma
por: Fusco, Pina, et al.
Publicado: (2018) -
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
por: Schleiermacher, G, et al.
Publicado: (2007) -
Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24
por: Abel, F, et al.
Publicado: (1999)